Drugmakers to start refunding Medicare for certain drugs that get thrown out; scientists see need for more data on CRISPR treatment's risk

Currently, Medicare pays for the entire vial or container regardless of what's tossed out, including for cancer medications. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        STAT+: Drug companies will have to start refunding Medicare for certain drugs that get thrown out By Bob Herman Adobe Starting in 2023, Medicare will be refunded for the unused portions of injectable and infused drugs administered by physicians in outpatient clinics. Read More STAT+: Beyond a CRISPR treatment's encouraging results, some scientists see a need for more data on risk By Jason Mast Adobe Vertex, they say, has not released key information on precisely how CRISPR is impacting the DNA of patients in its trials. Read More STAT+: Remote technology could nudge patients to join cancer clinical trials By Mario Aguilar and Mohana Ravindranath Adobe In the latest edition of STAT Health Tech: technology to boost participation in clinical trials and a new name for Watson Health's assets. Read More Sponsor content by BIO-RAD LABORATORIES Discover the power of Droplet Digital PCR for hematology-oncology applications For translational and clinical hematology-oncology research, the ability to identify and measure rare nucleic acid sequences is essential. This capability allows reliable detection and monitoring of cancer, even when molecular markers are in very low abundance. Bio-Rad’s proven Droplet Digital PCR HemOnc solutions provide absolute quantification of amplified DNA and RNA with unmatched precision without standard curves. STAT+: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans By Lev Facher Michael Reynolds/AP Francis Collins is making progress in finding a director for ARPA-H, and he’s turned to a natural proving ground for candidates: DARPA. Read More Tuesday, July 12, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser